AU2002257587A1 - Novel medicament compositions on the basis of anticholinergics and PDE IV inhibitors - Google Patents

Novel medicament compositions on the basis of anticholinergics and PDE IV inhibitors

Info

Publication number: AU2002257587A1
Authority: AU; Australia
Prior art keywords: anticholinergics; pde; inhibitors; basis; medicament compositions
Prior art date: 2001-03-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002257587A

Other versions

AU2002257587B2 (en

Inventor

Christopher John Montague Meade

Michel Pairet

Michael Paul Pieper

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Boehringer Ingelheim Pharma GmbH and Co KG

Original Assignee

Boehringer Ingelheim Pharma GmbH and Co KG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-07

Filing date

2002-02-26

Publication date

2003-03-13

2001-03-07 Priority claimed from DE10110772A external-priority patent/DE10110772A1/en

2002-02-26 Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG

2003-03-13 Publication of AU2002257587A1 publication Critical patent/AU2002257587A1/en

2007-05-10 Application granted granted Critical

2007-05-10 Publication of AU2002257587B2 publication Critical patent/AU2002257587B2/en

2022-02-26 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10110772A DE10110772A1 (en)	2001-03-07	2001-03-07	New drug compositions based on anticholinergics and PDE-IV inhibitors
DE10110772.2		2001-03-07
PCT/EP2002/001988 WO2002069945A2 (en)	2001-03-07	2002-02-26	Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors

Publications (2)

Publication Number	Publication Date
AU2002257587A1 true AU2002257587A1 (en)	2003-03-13
AU2002257587B2 AU2002257587B2 (en)	2007-05-10

Family

ID=7676493

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002257587A Ceased AU2002257587B2 (en)	2001-03-07	2002-02-26	Novel medicament compositions on the basis of anticholinergics and PDE IV inhibitors

Country Status (18)

Country	Link
EP (1)	EP1372649B1 (en)
JP (1)	JP2004521134A (en)
KR (1)	KR20030081501A (en)
CN (1)	CN1649588A (en)
AR (1)	AR034213A1 (en)
AU (1)	AU2002257587B2 (en)
BR (1)	BR0207883A (en)
CA (1)	CA2439763C (en)
CZ (1)	CZ20032635A3 (en)
DE (1)	DE10110772A1 (en)
EA (1)	EA009989B1 (en)
HU (1)	HUP0400782A3 (en)
IL (2)	IL157326A0 (en)
MX (1)	MXPA03008045A (en)
NZ (1)	NZ528621A (en)
PL (1)	PL363078A1 (en)
TW (1)	TWI332833B (en)
WO (1)	WO2002069945A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
WO2002096423A2 (en) *	2001-05-25	2002-12-05	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways
GB0118373D0 (en) *	2001-07-27	2001-09-19	Glaxo Group Ltd	Novel therapeutic method
US20030235538A1 (en)	2002-04-09	2003-12-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Method for the administration of an anticholinergic by inhalation
DE10230769A1 (en) *	2002-07-09	2004-01-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	New drug compositions based on new anticholinergics and PDE-IV inhibitors
EP1610788A1 (en) *	2003-03-28	2006-01-04	ALTANA Pharma AG	Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
ES2300755T3 (en) *	2003-03-28	2008-06-16	Nycomed Gmbh	SYNERGIC COMBINATION INCLUDING ROFLUMILAST AND AN ANTI-POLINERGIC AGENT SELECTED FROM TIOTROPIO SALTS FOR THE TREATMENT OF RESPIRATORY DISEASES.
WO2004084894A1 (en) *	2003-03-28	2004-10-07	Altana Pharma Ag	Synergistic combination comprising roflumilast and revatropate for the treatment of respiratory diseases
TWI328009B (en)	2003-05-21	2010-08-01	Glaxo Group Ltd	Quinoline derivatives as phosphodiesterase inhibitors
EP1651208A1 (en) *	2003-07-28	2006-05-03	Boehringer Ingelheim International GmbH	Medicaments comprising pde iv inhibitors and a novel anticholinergic and their use for treating respiratory disorders
US7071333B2 (en)	2003-07-30	2006-07-04	Bristol-Myers Squibb Company	Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
EP1504756A1 (en) *	2003-08-06	2005-02-09	Kyowa Hakko Kogyo Co., Ltd	Medicament compositions comprising a heterocyclic compound and an anticholinergic
WO2005067929A1 (en) *	2004-01-09	2005-07-28	Boehringer Ingelheim International Gmbh	New pharmaceutical compositions based on a scopineester and nicotinamide derivatives
AU2005210086A1 (en) *	2004-02-06	2005-08-18	Meda Pharma Gmbh & Co. Kg	Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
DK1713471T3 (en)	2004-02-06	2012-05-14	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
RU2440813C2 (en)	2004-02-06	2012-01-27	Меда Фарма Гмбх Унд Ко.Кг	Combination (versions) and pharmaceutical preparation for treating upper respiratory tract diseases
WO2005082361A1 (en) *	2004-02-27	2005-09-09	Altana Pharma Ag	Roflumilast and glycopryrronium combination
EP1616567A1 (en) *	2004-07-16	2006-01-18	Boehringer Ingelheim Pharma GmbH & Co.KG	Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
DK1863476T3 (en)	2005-03-16	2016-05-17	Meda Pharma Gmbh & Co Kg	Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
GB0521563D0 (en)	2005-10-21	2005-11-30	Glaxo Group Ltd	Novel compounds
CA2632780C (en)	2005-12-21	2013-11-12	Meda Pharma Gmbh & Co. Kg	Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases
DK2046787T3 (en)	2006-08-01	2011-07-18	Glaxo Group Ltd	Pyrazolo [3,4-B] pyridine compounds, and their use as PDE4 inhibitors
EP2100598A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100599A1 (en)	2008-03-13	2009-09-16	Laboratorios Almirall, S.A.	Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US8470835B2 (en)	2009-01-13	2013-06-25	Glaxo Group Limited	Pyrimidinecarboxamide derivatives as inhibitors of Syk kinase
WO2012025473A1 (en)	2010-08-24	2012-03-01	Glaxo Group Limited	Cc.chemokine receptor 4 antagonists
WO2012025474A1 (en)	2010-08-24	2012-03-01	Glaxo Group Limited	Indazole compounds
EP2510928A1 (en)	2011-04-15	2012-10-17	Almirall, S.A.	Aclidinium for use in improving the quality of sleep in respiratory patients
CN102670607A (en) *	2012-05-28	2012-09-19	海南卫康制药(潜山)有限公司	Compound ambroxol hydrochloride composition and preparation method thereof
RU2666624C2 (en) *	2013-03-15	2018-09-11	ВЕРОНА ФАРМА ПиэЛСи	Drug combination
US10105148B2 (en) *	2013-05-31	2018-10-23	Incipio Devices Sa	Acetabular reamer assembly

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2000198734A (en) *	1998-12-30	2000-07-18	Pfizer Inc	Motility enhancers for the treatment of gastric motility impairment and related disorders
MY134008A (en) *	1999-12-22	2007-11-30	Merck Frosst Canada Inc	Subtituted 8-arylquinoline phospohodiestrase-4 inhibitors
DE60103976T2 (en) *	2000-01-31	2005-07-21	Pfizer Products Inc., Groton	PYRIMIDINYL CARBOXAMIDES AS INHIBITORS OF PDE4 ISOENZYME
AU2001239550A1 (en) *	2000-03-23	2001-10-03	Takeda Chemical Industries Ltd.	Furoisoquinoline derivatives, process for producing the same and use thereof
GB0009583D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Respiratory formulations
US20020052312A1 (en) *	2000-05-30	2002-05-02	Reiss Theodore F.	Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
AR029984A1 (en) *	2000-07-27	2003-07-23	Smithkline Beecham Corp	METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO

2001
- 2001-03-07 DE DE10110772A patent/DE10110772A1/en not_active Withdrawn
2002
- 2002-02-26 CA CA2439763A patent/CA2439763C/en not_active Expired - Fee Related
- 2002-02-26 EA EA200300929A patent/EA009989B1/en not_active IP Right Cessation
- 2002-02-26 JP JP2002569122A patent/JP2004521134A/en active Pending
- 2002-02-26 WO PCT/EP2002/001988 patent/WO2002069945A2/en active IP Right Grant
- 2002-02-26 BR BR0207883-0A patent/BR0207883A/en active Pending
- 2002-02-26 CZ CZ20032635A patent/CZ20032635A3/en unknown
- 2002-02-26 EP EP02727329A patent/EP1372649B1/en not_active Expired - Lifetime
- 2002-02-26 AU AU2002257587A patent/AU2002257587B2/en not_active Ceased
- 2002-02-26 IL IL15732602A patent/IL157326A0/en unknown
- 2002-02-26 KR KR10-2003-7011716A patent/KR20030081501A/en not_active Ceased
- 2002-02-26 MX MXPA03008045A patent/MXPA03008045A/en active IP Right Grant
- 2002-02-26 PL PL02363078A patent/PL363078A1/en not_active Application Discontinuation
- 2002-02-26 NZ NZ528621A patent/NZ528621A/en not_active IP Right Cessation
- 2002-02-26 HU HU0400782A patent/HUP0400782A3/en not_active Application Discontinuation
- 2002-02-26 CN CNA02805346XA patent/CN1649588A/en active Pending
- 2002-03-06 AR ARP020100808A patent/AR034213A1/en active Pending
- 2002-03-06 TW TW091104144A patent/TWI332833B/en active
2003
- 2003-08-11 IL IL157326A patent/IL157326A/en not_active IP Right Cessation

Publication	Publication Date	Title
AU2002257587A1 (en)	2003-03-13	Novel medicament compositions on the basis of anticholinergics and PDE IV inhibitors
IL157326A0 (en)	2004-02-19	Novel medicament compositions on the basis of anticholinergics and pde iv inhibitors
AU2002363236A1 (en)	2003-05-12	Compounds, pharmaceutical compositions and methods of use therefor
AU2002335536A1 (en)	2003-07-03	Pyrimidine compound and medicinal composition thereof
AU2002338806A1 (en)	2003-04-14	Pharmaceutical combinations of pde-v inhibitors and other agents
AU2002305205A1 (en)	2002-11-05	9-deazaguanine derivatives as inhibitors of gsk-3
AU2001244355A1 (en)	2001-10-15	Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2003259735A1 (en)	2004-02-25	Small-mer compositions and methods of use
AU2002210575A1 (en)	2002-05-15	Novel medicament compositions based on anticholinergics and corticosteroids
IL164022A0 (en)	2005-12-18	Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
AU2003299441A1 (en)	2004-07-14	Nf-hev compositions and methods of use
AU2003260241A1 (en)	2004-03-29	Buguzhi agent and composition and methods of preparing and administering the same
AU2002248432A1 (en)	2002-08-28	Oxazole derivatives, their preparation and their use as cytokine inhibitors
AU2002238103A1 (en)	2002-08-28	Use of beta-lactamase inhibitors as neuroprotectants
AU2002241211A1 (en)	2002-10-15	Imidazo-triazine derivatives as pde 5 inhibitors
AU2003233445A1 (en)	2003-10-13	Antimicrobial compositions and methods of use
AU2002338734A1 (en)	2003-07-03	Use of phosphorodiesterase IV inhibitors
AU2002308889A1 (en)	2003-05-08	Novel heterocyclic compound and medicinal use thereof
AU2003242755A1 (en)	2004-01-23	Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors
AU2002303552A1 (en)	2002-11-18	Methods and compositions for prevention of angioproliferation
AU2002364911A1 (en)	2003-09-02	Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use
AU2001274022A1 (en)	2002-02-21	Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2003275069A1 (en)	2004-04-08	Compositions and methods for preventing infection
AU2003303948A1 (en)	2004-11-23	Compositions and methods for preventing infection
AU2003291458A1 (en)	2004-06-03	Pharmaceutical compositions and methods of using taxane derivatives